Prognosis of patients with advanced gastric cancer by HER2 status and trastuzumab treatment
Gastric Cancer, 07/27/2012
Clinical Article
Shitara K et al. – Recent HER2–positive advanced gastric cancer (AGC) patients have a better prognosis than HER2–negative patients, particularly when treated with trastuzumab.



